sofidexFor patientsAre you a clinician? Clinical site

Meds & supplements  ›  Levomilnacipran

Medicine

Levomilnacipran

FETZIMA ® is indicated for the treatment of major depressive disorder (MDD) in adults.

Medication guideLabel updated 2024-04-30

Selected manufacturer label information, organised into consistent sections by Sofidex. Read the full label at DailyMed ↗

Boxed warning

WARNING: SUICIDAL THOUGHTS AND BEHAVIORS Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors. FETZIMA is not approved for use in pediatric patients. WARNING: SUICIDAL THOUGHTS AND BEHAVIORS See full prescribing information for complete boxed warning. Increased risk of suicidal thoughts and behavior in pediatric and young adult patients taking antidepressants. Closely monitor all antidepressant-treated patients for clinical worsening and emergence of suicidal thoughts and behaviors.

Drug facts

Used for
  • The efficacy and safety of FETZIMA for the management of fibromyalgia have not been established.
  • FETZIMA is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of Major Depressive Disorder (MDD) in adults .
How to take it
Take FETZIMA exactly as your healthcare provider tells you to take it.

What it is used for

FETZIMA ® is indicated for the treatment of major depressive disorder (MDD) in adults. Limitation of Use: FETZIMA is not approved for the management of fibromyalgia. The efficacy and safety of FETZIMA for the management of fibromyalgia have not been established. FETZIMA is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of Major Depressive Disorder (MDD) in adults.

Limitation of Use: FETZIMA is not approved for the management of fibromyalgia. The efficacy and safety of FETZIMA for the management of fibromyalgia have not been established.

The most important thing to know

FETZIMA may cause serious side effects, including: Increased risk of suicidal thoughts and actions. FETZIMA and other antidepressant medicines may increase suicidal thoughts and actions in some people 24 years and younger, especially within the first few months of treatment or when the dose is changed. FETZ IMA is not for use in children.

Depression or other mental illnesses are the most important causes of suicidal thoughts or actions. How can I watch for and try to prevent suicidal thoughts and actions? Pay close attention to any changes, especially sudden changes in mood, behavior, thoughts, or feelings, or if you develop suicidal thoughts or actions.

This is very important when an antidepressant medicine is started or when the dose is changed. Call your healthcare provider right away to report new or sudden changes in mood, behavior, thoughts, or feelings or if you develop suicidal thoughts or actions. Keep all follow-up visits with your healthcare provider as scheduled.

Call your healthcare provider between visits as needed, especially if you have concerns about symptoms. Call your healthcare provider or get emergency medical help right away if you or your family member have any of the following symptoms, especially if the y are new, worse, or worry you: ● attempts to commit suicide ● acting on dangerous impulses ● acting aggressive, being angry or violent ● thoughts about suicide or dying ● new or worse depression ● new or worsening anxiety ● panic attacks ● feeling very agitated or restless ● new or worse irritability ● trouble sleeping ● an extreme increase in activity or talking (mania) ● other unusual changes in behavior or mood What is FETZIMA?

FETZIMA is a prescription medicine used to treat a certain type of depression called Major Depressive Disorder (MDD) in adults. It is not known if FETZIMA is safe and effective for use in children. It is not known if FETZIMA is safe and effective for the management of fibromyalgia. FETZIMA is not for use for the management of fibromyalgia.

How to take it

Take FETZIMA exactly as your healthcare provider tells you to take it. Do not change your dose or stop taking FETZIMA without first talking to your healthcare provider. Your healthcare provider may need to change the dose of FETZIMA until it is the right dose for you. Take FETZIMA 1 time each day at about the same time each day.

Take FETZIMA with or without food. Swallow FETZIMA capsules whole. Do not open, chew, or crush the FETZIMA capsule. If you miss a dose of FETZIMA, take the missed dose as soon as you remember. If it is almost time for the next dose, skip the missed dose and take your next dose at the regular time. Do not take 2 doses of FETZIMA at the same time.

If you take too much FETZIMA, call your healthcare provider or poison control center at 1-800-222-1222, or go to the nearest hospital emergency room right away.

Side effects, and when to stop

” Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.

Who should not take it

Do not take FETZIMA if you: are allergic to levomilnacipran, milnacipran HCl, or any of the ingredients in FETZIMA. See the end of this Medication Guide for a complete list of ingredients in FETZIMA. are taking or have taken within the last 14 days, a medicine called a monoamine oxidase inhibitor (MAOI), including the antibiotic linezolid or intravenous methylene blue.

Ask your healthcare provider or pharmacist if you are not sure if you take an MAOI, including the antibiotic linezolid or intravenous methylene blue. Do not start taking an MAOI for at least 7 days after you stop treatment with FETZIMA. Before taking FETZIMA, tell your healthcare provider about all your medical conditions, including if you: have or have a family history of suicide, depression, bipolar disorder, mania, or hypomania have high blood pressure have or had heart problems, including fast heartbeat, or stroke have or had bleeding problems have glaucoma (high pressure in the eye) have or had problems urinating (hesitation) or emptying your bladder (retention) have or had seizures (convulsions) have low sodium levels in your blood have or had kidney problems drink alcohol are pregnant or plan to become pregnant.

FETZIMA may harm your unborn baby. Taking FETZIMA during your third trimester of pregnancy may cause you to have an increased risk of bleeding after your delivery and may also cause your baby to be at increased risk for withdrawal symptoms, or breathing, temperature control, feeding or other problems at birth. Talk to your healthcare provider about the risks to you and your baby if you take FETZIMA during pregnancy.

Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with FETZIMA. There is a pregnancy registry for women who are exposed to FETZIMA during pregnancy. The purpose of the registry is to collect information about the health of women exposed to FETZIMA and their baby.

If you become pregnant during treatment with FETZIMA, talk to your healthcare provider about registering with the National Pregnancy Registry for Antidepressants at 1-844-405-6185 or visit online at https://womensmentalhealth.org/research/pregnancyregistry/antidepressants. are breastfeeding or plan to breastfeed. It is not known if FETZIMA passes into your breast milk.

Talk to your healthcare provider about the best way to feed your baby during treatment with FETZIMA. If you breastfeed during treatment with FETZIMA, call your healthcare provider if your baby develops sleepiness or fussiness, or is not feeding or gaining weight well. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

FETZIMA and other medicines may affect each other causing possible serious side effects. FETZIMA may affect the way other medicines work and other medicines may affect the way FETZIMA works. Especially tell your healthcare provider if you take: MAOIs medicines used to treat migraine headache known as triptans tricyclic antidepressants lithium tramadol, fentanyl, meperidine, methadone, or other opioids tryptophan buspirone amphetamines St.

John’s Wort medicines that can affect blood clotting such as aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs) and warfarin diuretics medicines used to treat mood, anxiety, psychotic or thought disorders, including selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs) Ask your healthcare provider if you are not sure if you are taking any of these medicines.

Your healthcare provider can tell you if it is safe to take FETZIMA with your other medicines. Do not start or stop any other medicines during treatment with FETZIMA without talking to your healthcare provider first. Stopping FETZIMA suddenly may cause you to have serious side effects. See, “

What to avoid

Do not drive, operate heavy machinery, or do other dangerous activities until you know how FETZIMA affects you. FETZIMA can cause sleepiness or may affect your ability to make decisions, think clearly, or react quickly. Avoid drinking alcohol during treatment with FETZIMA. What are the possible side effects of FETZIMA? FETZIMA may cause serious side effects, including: Serotonin syndrome.

A potentially life-threatening problem called serotonin syndrome can happen when FETZIMA is taken with certain other medicines. See “ Do not take FETZIMA if you. ” C all you r healthcare provider or go to the nearest hospital emergency room right away if you have any of the following signs and symptoms of serotonin syndrome: ○ agitation ○ seeing or hearing things that are not real (hallucinations) ○ confusion ○ coma ○ fast heartbeat ○ blood pressure changes ○ dizziness ○ sweating ○ flushing ○ high body temperature (hyperthermia) ○ tremors, stiff muscles, or muscle twitching ○ loss of coordination ○ seizures ○ nausea, vomiting, diarrhea High blood pressure (hypertension).

Your healthcare provider should check your blood pressure before you start and during treatment with FETZIMA. If you have high blood pressure, it should be controlled before you start treatment with FETZIMA. Increased heart rate. Your healthcare provider should check your heart rate before you start and during treatment with FETZIMA.

If you have heart problems or problems with an abnormal heartbeat, your problems should be treated before you start treatment with FETZIMA. Increased risk of bleeding. Taking FETZIMA with aspirin, non-steroidal anti-inflammatory drugs (NSAIDs), warfarin or blood thinners may add to this risk. Tell your healthcare provider right away about any unusual bleeding or bruising.

Eye problems (angle-closure glaucoma). FETZIMA may cause a type of eye problem called angle-closure glaucoma in people with certain eye problems. You may want to undergo an eye examination to see if you are at risk and receive preventative treatment if you are. Call your healthcare provider if you have changes in your vision, eye pain, or swelling or redness in or around the eye.

Problems with urination. FETZIMA may cause you to have problems with urination including decreased urine flow and being unable to pass any urine. Tell your healthcare provider if you develop any problems with urine flow during treatment with FETZIMA. Manic episodes. Manic episodes may happen in people with bipolar disorder who take FETZIMA.

Symptoms may include: ○ greatly increased energy ○ severe trouble sleeping ○ racing thoughts ○ reckless behavior ○ unusually grand ideas ○ excessive happiness or irritability ○ talking more or faster than usual Seizures (convulsions). Discontinuation syndrome. Suddenly stopping FETZIMA may cause you to have serious side effects.

Your healthcare provider may want to decrease your dose slowly. Symptoms may include: ○ changes in your mood ○ headache ○ irritability and agitation ○ tiredness ○ dizziness ○ problems sleeping ○ electric shock sensation (paresthesia) ○ hypomania ○ anxiety ○ ringing in your ears (tinnitus) ○ confusion ○ seizures Low sodium levels in your blood (hyponatremia).

Low sodium levels in your blood that may be serious and may cause death can happen during treatment with FETZIMA. Elderly people and people who take certain medicines may be at greater risk for this. Signs and symptoms may include: ○ headache ○ difficulty concentrating ○ memory changes ○ confusion ○ weakness and unsteadiness on your feet which can lead to falls In more severe or more sudden cases, signs and symptoms include: ○ hallucinations (seeing or hearing things that are not real) ○ fainting ○ seizures ○ coma ○ stopping breathing (respiratory arrest) Sexual problems (dysfunction).

Taking FETZIMA may cause sexual problems. Symptoms in males may include: ○ delayed ejaculation or inability to have an ejaculation ○

Storing it

Store FETZIMA at room temperature between 68°F to 77°F (20°C to 25°C). Keep FETZIMA and all medicines out of the reach of children.

Cite this page

NLM

sofidex [Internet]. Daloreum; c2026. Levomilnacipran; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/levomilnacipran

APA 7th

sofidex. (2026, August 2). Levomilnacipran. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/levomilnacipran

AMA 11th

Levomilnacipran. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/levomilnacipran

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.